Similarities and dissimilarities of COVID-19 and other coronavirus diseases

TS Fung, DX Liu - Annual review of microbiology, 2021 - annualreviews.org
In less than two decades, three deadly zoonotic coronaviruses, severe acute respiratory
syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS …

What coronavirus 3C‐like protease tells us: from structure, substrate selectivity, to inhibitor design

M Xiong, H Su, W Zhao, H Xie… - Medicinal Research …, 2021 - Wiley Online Library
The emergence of a variety of coronaviruses (CoVs) in the last decades has posed huge
threats to human health. Especially, the ongoing pandemic of coronavirus disease 2019 …

Peptidomimetic α-acyloxymethylketone warheads with six-membered lactam P1 glutamine mimic: SARS-CoV-2 3CL protease inhibition, coronavirus antiviral activity …

B Bai, A Belovodskiy, M Hena… - Journal of Medicinal …, 2021 - ACS Publications
Recurring coronavirus outbreaks, such as the current COVID-19 pandemic, establish a
necessity to develop direct-acting antivirals that can be readily administered and are active …

Perspectives on SARS-CoV-2 main protease inhibitors

K Gao, R Wang, J Chen, JJ Tepe… - Journal of medicinal …, 2021 - ACS Publications
The main protease (Mpro) plays a crucial role in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) replication and is highly conserved, rendering it one of the …

Benchmarking the ability of common docking programs to correctly reproduce and score binding modes in SARS-CoV-2 protease Mpro

S Zev, K Raz, R Schwartz, R Tarabeh… - Journal of Chemical …, 2021 - ACS Publications
The coronavirus SARS-CoV-2 main protease, Mpro, is conserved among coronaviruses with
no human homolog and has therefore attracted significant attention as an enzyme drug …

[HTML][HTML] Precision therapeutic targets for COVID-19

ZA Krumm, GM Lloyd, CP Francis, LH Nasif… - Virology journal, 2021 - Springer
Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …

[HTML][HTML] Crystal structure of SARS-CoV-2 main protease in complex with the non-covalent inhibitor ML188

GJ Lockbaum, AC Reyes, JM Lee, R Tilvawala… - Viruses, 2021 - mdpi.com
Viral proteases are critical enzymes for the maturation of many human pathogenic viruses
and thus are key targets for direct acting antivirals (DAAs). The current viral pandemic …

[HTML][HTML] A biochemical perspective of the nonstructural proteins (NSPs) and the spike protein of SARS CoV-2

FK Yoshimoto - The protein journal, 2021 - Springer
The global pandemic that shut down the world in 2020 was caused by the virus, SARS CoV-
2. The chemistry of the various nonstructural proteins (NSP3, NSP5, NSP12, NSP13 …

[PDF][PDF] Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing

S Durdagi, Ç Dağ, B Dogan, M Yigin, T Avsar… - Structure, 2021 - cell.com
The COVID-19 pandemic has resulted in 198 million reported infections and more than 4
million deaths as of July 2021 (covid19. who. int). Research to identify effective therapies for …

Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease

E Awoonor-Williams, AAAA Abu-Saleh - Physical Chemistry Chemical …, 2021 - pubs.rsc.org
COVID-19, the disease caused by the newly discovered coronavirus—SARS-CoV-2, has
created a global health, social, and economic crisis. As of mid-January 2021, there are over …